Clinical Trials Logo
  1. Home
  2. Rotavirus
  3. NCT03031743

The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan

Rotavirus Clinical Trial

Official title:
Nested Case-control Analysis of the Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan

Clinical Trial Summary

This is a nested case-control study within an ongoing rotavirus vaccine immunogenicity trial in Karachi, Pakistan. The primary study aim is to compare the fecal microbiota composition and diversity of infants who do (control) and do not (case) demonstrate immune seroconversion to rotavirus vaccination. The infants will be matched for vaccination dose, age and breast-feeding practices.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03031743
Study type Observational
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact
Status Completed
Phase N/A
Start date January 2014
Completion date July 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT02907216 - Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants Phase 4
Completed NCT00496054 - Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021) Phase 3
Completed NCT03587389 - Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam Phase 4
Unknown status NCT02177799 - Surveillance Study of Acute Gastroenteritis in Hospitalized Children in Rural Area in Lebanon N/A
Completed NCT01871038 - Rotarix Vaccine Effectiveness N/A
Terminated NCT00836498 - A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027) Phase 1
Completed NCT02141204 - Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants Phase 3
Enrolling by invitation NCT02153866 - The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine Phase 4
Completed NCT00820261 - Molecular Epidemiology of Rotavirus Diarrhea Among Infants and Young Children Attending Maua Methodist Hospital, Kenya N/A
Completed NCT00718237 - Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED) Phase 3
Completed NCT00166517 - V260 Registration Study (V260-013)(COMPLETED) Phase 3